Praxis Precision Medicines stock jumps over 235% today- Here’s why investors are paying attention
PRAX stock: Discover why investors are buzzing about Praxis Precision Medicines stock with a significant jump of over 235% following positive Phase 3 trial results for essential tremor treatment.
PRAX stock: Discover why investors are buzzing about Praxis Precision Medicines stock with a significant jump of over 235% following positive Phase 3 trial results for essential tremor treatment.
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
